“The efficacy and safety of two schemes of desensitization to trimethoprim-sulfamethoxazole in HIV-positive patients”, Rev Alerg Mex, vol. 67, no. 3, pp. 237–244, Jan. 2021, doi: 10.29262/ram.v67i3.745.